Back

DAPT, monotherapy, or more? Rethinking antithrombotic strategies after percutaneous coronary intervention

30 August 2025 (17:30 - 17:50)
Organised by: Logo
Congress Presentation Part of: Beyond stenting: optimising adjunctive pharmacotherapy for myocardial infarction Adjunctive Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Davide Capodanno

University of Catania, Catania (Italy)

2 More presentations in this session

Presentation thumbnail
If the stent looks good, why do patients still fail? the case for anti-inflammatory therapy
Doctor J. Rymer (Durham, US)
Slides Video
Presentation thumbnail
Fix the plaque, fight the lipids: why low-density lipoproteins still matter after percutaneous coronary intervention
Professor F. Visseren (Utrecht, NL)
Slides Video

Access the full session

Session thumbnail
Beyond stenting: optimising adjunctive pharmacotherapy for myocardial infarction
Video

The Event

Event poster

ESC Congress 2025

30 August 2025 17:30 CET
You may be interested in
thumbnail
Congress Presentation
Long-term antithrombotic strategy
thumbnail
Congress Session
Personalised dual antiplatelet therapy (DAPT) after acute coronary syndromes: difficult decisions
thumbnail
Congress Presentation
State-of-the-art lecture on adjunctive antiplatelet therapy for patients undergoing percutaneous coronary intervention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources